LAS VEGAS, Dec. 2 /PRNewswire-FirstCall/ -- VMT Scientific, Inc. announces accomplishment of its first step in its accelerated time line to meet public and professional pressure in maturing our technology. We are proud to announce that a prototype of the hand unit has been developed and available for POC (Proof of Concept) testing. "Though these prototypes are rudimentary, they are more then sufficient to help establish the base line concept efficacy," says VMT's CTO. We look forward to the delivery of several of these units to our PI (Principle Investigator) Dr. Jacques D. Barth, MD, PhD, FACC, FAHA for his personal inspection. We encourage everyone to visit our web site at www.vmtf.org to see more details on our technology.
This Press Release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these forward-looking statements. These statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in the forward- looking statements, particularly those risks and uncertainties inherent in the process of developing, medical products and Clinical trials. Factors that may cause such a difference include risks related to VMT Scientific Inc.'s limited operating history, risks associated with completing development and obtaining FDA medical approvals, successful patent protection and prosecution, successful sale of licensed technology nationally or internationally. VMT Scientific technology will not meet with market acceptance, the risk of future warranty and product liability claims, the uncertainty of VMT Scientifics' future access to capital to sustain operations, achieve profitability or continue as a going concern, the failure by VMT Scientific to secure and maintain relationships with suppliers, manufacturers and other third parties, reliance on key employees, and dependence on intellectual property. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from our current expectations.
VMT Scientific, Inc.
CONTACT: Catherine S. Ratelle, Director of Operations of VMT Scientific,Inc., +1-702-990-3477